A BIOMARKER FOR DETERMINING ALZHEIMER'S DISEASE

Abstract: the present disclosure relates to a method for determining a risk of development or risk of presence of alzheimer's disease in a human subject comprising analyzing an activity of a piezo1 receptor. the disclosure also relates to a kit for determining a risk of development or risk of presence of alzheimer's disease according to the present method. the disclosure also relates to an in vitro use of a piezo1 receptor as a biomarker and determination of intracellular calcium level as a biomarker for determining a risk of development or risk of presence of alzheimer's disease in a human subject.

Inventor(s): Tarja MALM, Rashid GINIATULLIN, Ilpo KURONEN, Ilkka FAGERLUND, Dilyara NURKHAMETOVA

CPC Classification: G01N33/5091 ({for testing the pathological state of an organism})

Search for rejections for patent application number 20250231178